Dr. Lieberman successfully renewed his NIH R01 grant

Dr. Lieberman successfully renewed his NIH R01 entitled Mechanisms of Radioresistance and Cell Cycle Progression from the National Cancer Institute in the amount of $1.7 million over 5 years.